Incremental Value of FDG-PET in the Evaluation of Cardiac Masses
- 3 June 2021
- journal article
- review article
- Published by Springer Nature in Current Cardiology Reports
- Vol. 23 (7) , 1-9
Abstract
Purpose of Review This study aims to review the various roles and evidence underlying the use of fluorodeoxyglucose (FDG) PET/CT and PET/MR for the assessment of cardiac masses. Recent Findings The role of FDG-PET for the evaluation of cardiac masses continues to evolve. Studies have shown that FDG-PET is particularly well-suited for differentiating malignant from benign cardiac lesions based on their metabolic activity. Furthermore, FDG-PET is uniquely positioned to investigate patients with cardiac mass as most malignant cardiac lesions are metastasis. Finally, FDG-PET enables staging of patients with primary malignant cardiac tumor, identification of potential biopsy site, and planning of radiotherapy. Summary FDG-PET is a complementary tool for the evaluation of patients with cardiac mass and can help differentiate benign from malignant lesions, as well as provide whole-body staging.Keywords
This publication has 46 references indexed in Scilit:
- 18F-FDG PET/CT Imaging in Primary Cardiac AngiosarcomaClinical Nuclear Medicine, 2013
- Imaging characteristics of cardiac dominant diffuse large B-cell lymphoma demonstrated with MDCT and PET/CTEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosisJournal of Nuclear Cardiology, 2013
- Primary Cardiac Lymphoma: Echocardiography and F‐18‐Fluorodeoxyglucose Positron Emission Tomography in Selection of a Biopsy SiteEchocardiography, 2012
- Differentiation of Malignant and Benign Cardiac Tumors Using 18F-FDG PET/CTJournal of Nuclear Medicine, 2012
- Differentiation of malignant from benign heart and pericardial lesions using positron emission tomography and computed tomographyJournal of Nuclear Cardiology, 2011
- Cardiac metastasesJournal of Clinical Pathology, 2006
- Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.American Journal of Roentgenology, 1997
- Frequency of primary tumors of the heartThe American Journal of Cardiology, 1996
- The heart in malignant melanomaThe American Journal of Cardiology, 1968